Prognostic value of brain natriuretic peptide (BNP) in patients with pulmonary arterial hypertension (PAH)
MH Williams, JG Coghlan(Royal Free London NHS Foundation Trust), CE Handler, Chandan Das(Indian Institute of Technology Guwahati), Akram, CP Denton(The Royal Free Hospital), Devi G. Nair(Bon Secours Heart & Vascular Institute), CM Black, Colette Smith(MRC Clinical Trials Unit at UCL), E Neville, Joanna Smee(Charing Cross Hospital)
UCL Discovery (University College London)
May 1, 2005
Cited by 0
Related Papers
Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach
|Annals of the Rheumatic Diseases|2003|769
Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial
|Annals of the Rheumatic Diseases|2010|503
The epidemiology of adolescents living with perinatally acquired HIV: A cross-region global cohort analysis
|PLoS Medicine|2018|173
Associations between integrase strand-transfer inhibitors and cardiovascular disease in people living with HIV: a multicentre prospective study from the RESPOND cohort consortium
|The Lancet HIV|2022|140
Open-Label Trial of Anti-TNF-α in Dermato- and Polymyositis Treated Concomitantly with Methotrexate
|European Neurology|2008|99